TreeWAS – Variant ID: rs9810233

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
M25.56 Pain in joint (Lower leg)	0.101	0.899	0.000
N80.1 Endometriosis of ovary	0.073	0.927	0.000
N80 Endometriosis	0.065	0.935	0.000
N80.9 Endometriosis, unspecified	0.061	0.939	0.000
N80.5 Endometriosis of intestine	0.057	0.943	0.000
N80.4 Endometriosis of rectovaginal septum and vagina	0.052	0.948	0.000
N80.0 Endometriosis of uterus	0.050	0.950	0.000
N80.6 Endometriosis in cutaneous scar	0.050	0.950	0.000
N80.2 Endometriosis of Fallopian tube	0.049	0.951	0.000
N80.8 Other endometriosis	0.046	0.954	0.000
Z74.0 Reduced mobility	0.000	0.955	0.045
N80.3 Endometriosis of pelvic peritoneum	0.035	0.965	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.968	0.032
Z74 Problems related to care-provider dependency	0.000	0.972	0.028
Z74.1 Need for assistance with personal care	0.000	0.976	0.024
Z74.9 Problem related to care-provider dependency, unspecified	0.000	0.977	0.023
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.977	0.023
Z74.3 Need for continuous supervision	0.000	0.980	0.020
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.980	0.020
Z74.8 Other problems related to care-provider dependency	0.000	0.980	0.020
Z74.2 Need for assistance at home and no other household member able to render care	0.000	0.981	0.019
T43.2 Other and unspecified antidepressants	0.000	0.982	0.018
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.982	0.018
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.983	0.017
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.983	0.016
C85.0 Lymphosarcoma	0.000	0.983	0.016
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.984	0.016
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.984	0.016
L57.0 Actinic keratosis	0.000	0.985	0.015
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.985	0.015
T43.6 Psychostimulants with abuse potential	0.000	0.987	0.013
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.987	0.013
T43.9 Psychotropic drug, unspecified	0.000	0.987	0.013
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.987	0.013
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.988	0.011
N04.9 Unspecified	0.011	0.989	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.989	0.011
C88 Malignant immunoproliferative diseases	0.000	0.990	0.010
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.990	0.010
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.991	0.009
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.991	0.009
N04 Nephrotic syndrome	0.009	0.991	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.991	0.009
N04.2 Diffuse membranous glomerulonephritis	0.008	0.991	0.000
C83.1 Small cleaved cell (diffuse)	0.000	0.992	0.008
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.992	0.008
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.992	0.008
C88.7 Other malignant immunoproliferative diseases	0.000	0.992	0.008
C88.3 Immunoproliferative small intestinal disease	0.000	0.992	0.008
C88.2 Gamma heavy chain disease	0.000	0.992	0.008
C88.1 Alpha heavy chain disease	0.000	0.992	0.008
C83.0 Small cell (diffuse)	0.000	0.992	0.008
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.992	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.993	0.007
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.993	0.007
N04.0 Minor glomerular abnormality	0.007	0.993	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.993	0.007
C82.2 Large cell, follicular	0.000	0.993	0.007
C86 Other specified types of T/NK-cell lymphoma	0.000	0.993	0.007
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.993	0.007
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.993	0.007
C94 Other leukaemias of specified cell type	0.000	0.993	0.007
N04.8 Other	0.007	0.993	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.007	0.993	0.000
N04.6 Dense deposit disease	0.007	0.993	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.007	0.993	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.007	0.993	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.007	0.993	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.007	0.993	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.993	0.007
C83.5 Lymphoblastic (diffuse)	0.000	0.993	0.007
C83.4 Immunoblastic (diffuse)	0.000	0.993	0.007
C83.3 Large cell (diffuse)	0.000	0.993	0.007
C83.2 Mixed small and large cell (diffuse)	0.000	0.993	0.007
T39.0 Salicylates	0.000	0.993	0.007
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.993	0.007
N04.1 Focal and segmental glomerular lesions	0.006	0.993	0.000
C95 Leukaemia of unspecified cell type	0.000	0.993	0.006
C93 Monocytic leukaemia	0.000	0.994	0.006
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.994	0.006
C82.0 Small cleaved cell, follicular	0.000	0.994	0.006
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.994	0.006
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.994	0.006
C56 Malignant neoplasm of ovary	0.000	0.994	0.006
N00-N08 Glomerular diseases	0.006	0.994	0.000
H40.9 Glaucoma, unspecified	0.006	0.994	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.994	0.006
C82.5 Diffuse follicle centre lymphoma	0.000	0.994	0.006
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.994	0.006
T39.4 Antirheumatics, not elsewhere classified	0.000	0.994	0.005
T39.2 Pyrazolone derivatives	0.000	0.994	0.005
L57.4 Cutis laxa senilis	0.000	0.995	0.005
N75.1 Abscess of Bartholin's gland	0.000	0.995	0.005
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.995	0.005
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.995	0.005
C83.7 Burkitt's tumour	0.000	0.995	0.005
I50.9 Heart failure, unspecified	0.005	0.995	0.000
C82.3 Follicular lymphoma grade IIIa	0.000	0.995	0.005
N03 Chronic nephritic syndrome	0.005	0.995	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.995	0.005
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.995	0.005
L57.5 Actinic granuloma	0.000	0.995	0.005
L57.3 Poikiloderma of Civatte	0.000	0.995	0.005
L57.2 Cutis rhomboidalis nuchae	0.000	0.995	0.005
L57.1 Actinic reticuloid	0.000	0.995	0.005
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.995	0.005
C86.4 Blastic NK-cell lymphoma	0.000	0.995	0.005
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.995	0.005
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.995	0.005
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.995	0.005
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.995	0.005
T39.1 4-Aminophenol derivatives	0.000	0.995	0.005
C94.7 Other specified leukaemias	0.000	0.995	0.005
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.995	0.005
C94.5 Acute myelofibrosis	0.000	0.995	0.005
C94.4 Acute panmyelosis	0.000	0.995	0.005
C94.3 Mast cell leukaemia	0.000	0.995	0.005
C94.2 Acute megakaryoblastic leukaemia	0.000	0.995	0.005
C94.1 Chronic erythraemia	0.000	0.995	0.005
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.995	0.005
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.995	0.005
C96.8 Histiocytic sarcoma	0.000	0.995	0.005
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.995	0.005
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.995	0.005
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.995	0.005
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.995	0.005
C96.3 True histiocytic lymphoma	0.000	0.995	0.005
C96.2 Malignant mast cell tumour	0.000	0.995	0.005
C96.1 Malignant histiocytosis	0.000	0.995	0.005
C96.0 Letterer-Siwe disease	0.000	0.995	0.005
J92.9 Pleural plaque without asbestos	0.005	0.995	0.000
H26.8 Other specified cataract	0.005	0.995	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.995	0.005
C82.4 Follicular lymphoma grade IIIb	0.000	0.995	0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.995	0.005
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.995	0.005
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
C95.7 Other leukaemia of unspecified cell type	0.000	0.995	0.005
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.995	0.005
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.995	0.005
C95.0 Acute leukaemia of unspecified cell type	0.000	0.995	0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.995	0.005
N05 Unspecified nephritic syndrome	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.995	0.005
C93.9 Monocytic leukaemia, unspecified	0.000	0.995	0.005
C93.7 Other monocytic leukaemia	0.000	0.995	0.005
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.995	0.005
C93.2 Subacute monocytic leukaemia	0.000	0.995	0.005
C93.0 Acute monocytic leukaemia	0.000	0.995	0.005
N03.9 Unspecified	0.005	0.995	0.000
C81 Hodgkin's disease	0.000	0.995	0.005
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.995	0.005
M25.5 Pain in joint	0.005	0.995	0.000
M25.52 Pain in joint (Upper arm)	0.005	0.995	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.000	0.995	0.004
C95.9 Leukaemia, unspecified	0.000	0.995	0.004
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.995	0.004
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.995	0.004
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.995	0.004
C84.3 Lymphoepithelioid lymphoma	0.000	0.995	0.004
C84.2 T-zone lymphoma	0.000	0.995	0.004
C84.1 Sezary's diease	0.000	0.995	0.004
D32.9 Meninges, unspecified	0.000	0.995	0.005
N02 Recurrent and persistent haematuria	0.005	0.995	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.996	0.004
C93.1 Chronic monocytic leukaemia	0.000	0.996	0.004
C84.4 Peripheral T-cell lymphoma	0.000	0.996	0.004
N07 Hereditary nephropathy, not elsewhere classified	0.004	0.996	0.000
N06 Isolated proteinuria with specified morphological lesion	0.004	0.996	0.000
N01 Rapidly progressive nephritic syndrome	0.004	0.996	0.000
N00 Acute nephritic syndrome	0.004	0.996	0.000
J32.4 Chronic pansinusitis	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
J32.2 Chronic ethmoidal sinusitis	0.000	0.996	0.004
N05.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.996	0.004
N05.9 Unspecified	0.004	0.996	0.000
N03.8 Other	0.004	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.996	0.004
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.996	0.004
T47.7 Emetics	0.000	0.996	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.996	0.004
T47.5 Digestants	0.000	0.996	0.004
T47.3 Saline and osmotic laxatives	0.000	0.996	0.004
T47.0 Histamine H(2)-receptor antagonists	0.000	0.996	0.004
N02.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
C92 Myeloid leukaemia	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
C84.0 Mycosis fungoides	0.000	0.996	0.004
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.004	0.996	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N03.6 Dense deposit disease	0.004	0.996	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N03.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
N03.0 Minor glomerular abnormality	0.004	0.996	0.000
T47.4 Other laxatives	0.000	0.996	0.004
M25.59 Pain in joint (Site unspecified)	0.004	0.996	0.000
N03.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.996	0.004
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.004
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
N05.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
C81.0 Lymphocytic predominance	0.000	0.996	0.004
N05.8 Other	0.004	0.996	0.000
T46.1 Calcium-channel blockers	0.000	0.996	0.004
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.004	0.996	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
T44.0 Anticholinesterase agents	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.004
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.004
T45.4 Iron and its compounds	0.000	0.996	0.004
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.004
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.996	0.004
T41.5 Therapeutic gases	0.000	0.996	0.004
T41.4 Anaesthetic, unspecified	0.000	0.996	0.004
T41.3 Local anaesthetics	0.000	0.996	0.004
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
T41.1 Intravenous anaesthetics	0.000	0.996	0.004
T41.0 Inhaled anaesthetics	0.000	0.996	0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
T48.5 Anti-common-cold drugs	0.000	0.996	0.004
T48.4 Expectorants	0.000	0.996	0.004
T48.3 Antitussives	0.000	0.996	0.004
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.004
T48.0 Oxytocic drugs	0.000	0.996	0.004
T49.9 Topical agent, unspecified	0.000	0.996	0.004
T49.8 Other topical agents	0.000	0.996	0.004
T49.7 Dental drugs, topically applied	0.000	0.996	0.004
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.004
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.004
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.004
T49.2 Local astringents and local detergents	0.000	0.996	0.004
T49.1 Antipruritics	0.000	0.996	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.004
C81.1 Nodular sclerosis	0.000	0.996	0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.996	0.004
T37.5 Antiviral drugs	0.000	0.996	0.004
T37.4 Anthelminthics	0.000	0.996	0.004
T37.3 Other antiprotozoal drugs	0.000	0.996	0.004
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.996	0.004
T37.1 Antimycobacterial drugs	0.000	0.996	0.004
T37.0 Sulphonamides	0.000	0.996	0.004
N05.6 Dense deposit disease	0.004	0.996	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N05.0 Minor glomerular abnormality	0.004	0.996	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.996	0.003
C81.3 Lymphocytic depletion	0.000	0.996	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.004
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.996	0.003
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.996	0.004
T47.2 Stimulant laxatives	0.000	0.996	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.996	0.004
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.996	0.004
T46.7 Peripheral vasodilators	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.996	0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.996	0.004
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.996	0.004
C81.7 Other Hodgkin's disease	0.000	0.996	0.003
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.000	0.996	0.004
N05.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
J32 Chronic sinusitis	0.000	0.996	0.004
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.003
T36.8 Other systemic antibiotics	0.000	0.996	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.003
T36.6 Rifamycins	0.000	0.996	0.003
T36.5 Aminoglycosides	0.000	0.996	0.003
T36.4 Tetracyclines	0.000	0.996	0.003
T36.3 Macrolides	0.000	0.996	0.003
T36.2 Chloramphenicol group	0.000	0.996	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.003
C81.2 Mixed cellularity	0.000	0.996	0.003
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N02.6 Dense deposit disease	0.003	0.996	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N02.1 Focal and segmental glomerular lesions	0.003	0.996	0.000
N02.0 Minor glomerular abnormality	0.003	0.996	0.000
M25.57 Pain in joint (Ankle and foot)	0.003	0.997	0.000
N00.9 Unspecified	0.003	0.997	0.000
N00.8 Other	0.003	0.997	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N00.6 Dense deposit disease	0.003	0.997	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N00.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N00.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N00.0 Minor glomerular abnormality	0.003	0.997	0.000
N01.9 Unspecified	0.003	0.997	0.000
N01.8 Other	0.003	0.997	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N01.6 Dense deposit disease	0.003	0.997	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N01.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N01.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N01.0 Minor glomerular abnormality	0.003	0.997	0.000
N06.9 Unspecified	0.003	0.997	0.000
N06.8 Other	0.003	0.997	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N06.6 Dense deposit disease	0.003	0.997	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N06.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N06.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N06.0 Minor glomerular abnormality	0.003	0.997	0.000
N07.9 Unspecified	0.003	0.997	0.000
N07.8 Other	0.003	0.997	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N07.6 Dense deposit disease	0.003	0.997	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N07.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N07.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N07.0 Minor glomerular abnormality	0.003	0.997	0.000
Z11 Special screening examination for infectious and parasitic diseases	0.003	0.997	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.997	0.003
J32.8 Other chronic sinusitis	0.000	0.997	0.003
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
N08 Glomerular disorders in diseases classified elsewhere	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
J32.0 Chronic maxillary sinusitis	0.000	0.997	0.003
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
E23.0 Hypopituitarism	0.000	0.997	0.003
M25.53 Pain in joint (Forearm)	0.003	0.997	0.000
C45.9 Mesothelioma, unspecified	0.003	0.997	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.997	0.003
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.997	0.003
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.997	0.003
C92.5 Acute myelomonocytic leukaemia	0.000	0.997	0.003
C92.3 Myeloid sarcoma	0.000	0.997	0.003
C92.2 Subacute myeloid leukaemia	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
M25.58 Pain in joint (Other)	0.003	0.997	0.000
C92.4 Acute promyelocytic leukaemia	0.000	0.997	0.003
Z11.5 Special screening examination for other viral diseases	0.003	0.997	0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.000	0.997	0.003
N02.9 Unspecified	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.003
M10.99 Gout, unspecified (Site unspecified)	0.003	0.997	0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
L58 Radiodermatitis	0.000	0.997	0.003
L55 Sunburn	0.000	0.997	0.003
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
J32.3 Chronic sphenoidal sinusitis	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
J92 Pleural plaque	0.003	0.997	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.997	0.003
C92.7 Other myeloid leukaemia	0.000	0.997	0.003
N02.8 Other	0.003	0.997	0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.000	0.997	0.003
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T14.6 Injury of tendons and muscles of unspecified body region	0.003	0.997	0.000
T42.1 Iminostilbenes	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
J92.0 Pleural plaque with presence of asbestos	0.003	0.997	0.000
C91 Lymphoid leukaemia	0.000	0.997	0.003
Z11.8 Special screening examination for other infectious and parasitic diseases	0.003	0.997	0.000
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.003	0.997	0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
I74.8 Embolism and thrombosis of other arteries	0.000	0.997	0.003
L56.3 Solar urticaria	0.000	0.997	0.003
L56.2 Photocontact dermatitis [berloque dermatitis]	0.000	0.997	0.003
L56.1 Drug photoallergic response	0.000	0.997	0.003
L56.0 Drug phototoxic response	0.000	0.997	0.003
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.000	0.997	0.003
N08.8 Glomerular disorders in other diseases classified elsewhere	0.003	0.997	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.003	0.997	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.003	0.997	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.003	0.997	0.000
I74 Arterial embolism and thrombosis	0.000	0.997	0.003
S20.8 Superficial injuries of other and unspecified parts of thorax	0.003	0.997	0.000
T14.0 Superficial injury of unspecified body region	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.002
T14 Injury of unspecified body region	0.003	0.997	0.000
M25.54 Pain in joint (Hand)	0.003	0.997	0.000
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.000	0.997	0.002
L59.0 Erythema ab igne [dermatitis ab igne]	0.000	0.997	0.002
D75.8 Other specified diseases of blood and blood-forming organs	0.003	0.997	0.000
H34.8 Other retinal vascular occlusions	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.000	0.997	0.002
D75.2 Essential thrombocytosis	0.003	0.997	0.000
J32.1 Chronic frontal sinusitis	0.000	0.997	0.002
L56.4 Polymorphous light eruption	0.000	0.997	0.002
T14.4 Injury of nerve(s) of unspecified body region	0.002	0.997	0.000
I71 Aortic aneurysm and dissection	0.003	0.997	0.000
L55.9 Sunburn, unspecified	0.000	0.998	0.002
L55.8 Other sunburn	0.000	0.998	0.002
L55.2 Sunburn of third degree	0.000	0.998	0.002
L55.1 Sunburn of second degree	0.000	0.998	0.002
L55.0 Sunburn of first degree	0.000	0.998	0.002
L58.9 Radiodermatitis, unspecified	0.000	0.998	0.002
L58.1 Chronic radiodermatitis	0.000	0.998	0.002
L58.0 Acute radiodermatitis	0.000	0.998	0.002
C90.3 Solitary plasmacytoma	0.000	0.998	0.002
I71.0 Dissection of aorta [any part]	0.002	0.998	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.000	0.998	0.002
Z11.1 Special screening examination for respiratory tuberculosis	0.002	0.998	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
C45 Mesothelioma	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.000	0.998	0.002
M51.9 Intervertebral disk disorder, unspecified	0.000	0.998	0.002
N41.1 Chronic prostatitis	0.000	0.998	0.002
T91.8 Sequelae of other specified injuries of neck and trunk	0.000	0.998	0.002
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.002	0.998	0.000
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
H54.0 Blindness, both eyes	0.002	0.998	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.002	0.998	0.000
T14.1 Open wound of unspecified body region	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.998	0.002
C91.7 Other lymphoid leukaemia	0.000	0.998	0.002
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.998	0.002
C91.3 Prolymphocytic leukaemia	0.000	0.998	0.002
C91.2 Subacute lymphocytic leukaemia	0.000	0.998	0.002
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.002	0.998	0.000
M10.9 Gout, unspecified	0.002	0.998	0.000
T42.3 Barbiturates	0.000	0.998	0.002
S72.10 Pertrochanteric fracture (closed)	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
T91 Sequelae of injuries of neck and trunk	0.000	0.998	0.002
T91.1 Sequelae of fracture of spine	0.000	0.998	0.002
T14.2 Fracture of unspecified body region	0.002	0.998	0.000
T14.8 Other injuries of unspecified body region	0.002	0.998	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.002	0.998	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.002	0.998	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.001	0.998	0.001
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.998	0.002
J35.8 Other chronic diseases of tonsils and adenoids	0.002	0.998	0.000
Z11.2 Special screening examination for other bacterial diseases	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.002	0.998	0.000
H57.1 Ocular pain	0.002	0.998	0.000
Z88.3 Personal history of allergy to other anti-infective agents	0.002	0.998	0.000
D75.1 Secondary polycythaemia	0.002	0.998	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.002	0.998	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.002	0.998	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.002	0.998	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.000	0.998	0.002
D58.0 Hereditary spherocytosis	0.000	0.998	0.002
E11.5 With peripheral circulatory complications	0.000	0.998	0.002
D75 Other diseases of blood and blood-forming organs	0.002	0.998	0.000
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.998	0.002
R76.8 Other specified abnormal immunological findings in serum	0.000	0.998	0.002
T14.9 Injury, unspecified	0.002	0.998	0.000
C45.2 Mesothelioma of pericardium	0.002	0.998	0.000
C45.1 Mesothelioma of peritoneum	0.002	0.998	0.000
C45.0 Mesothelioma of pleura	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations